Strategies for Successful Transition of a Biologic Assay
Summary: Successfully transitioning a large molecule assay requires great attention to detail and comes with its own unique benefits and challenges. Mike Sadick, PhD, Principal Scientist, at Catalent Biologics discusses a recent project involving assay transfer from a cell-based Fluorescence-Activated Cell Sorting (FACS) assay to Amplified Luminescent Proximity Homogeneous Assay (AlphaLISA) technology.
Read the article to learn about the pros and cons of transitioning from one relative potency assay to another, with a focus on leveraging AlphaLISA technology.